HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Substrate inhibition of uracil phosphoribosyltransferase by uracil can account for the uracil growth sensitivity of Leishmania donovani pyrimidine auxotrophs.

Abstract
The pathogenic protozoan parasite Leishmania donovani is capable of both de novo pyrimidine biosynthesis and salvage of pyrimidines from the host milieu. Genetic analysis has authenticated L. donovani uracil phosphoribosyltransferase (LdUPRT), an enzyme not found in mammalian cells, as the focal enzyme of pyrimidine salvage because all exogenous pyrimidines that can satisfy the requirement of the parasite for pyrimidine nucleotides are funneled to uracil and then phosphoribosylated to UMP in the parasite by LdUPRT. To characterize this unique parasite enzyme, LdUPRT was expressed in Escherichia coli, and the recombinant enzyme was purified to homogeneity. Kinetic analysis revealed apparent Km values of 20 and 99 μM for the natural substrates uracil and phosphoribosylpyrophosphate, respectively, as well as apparent Km values 6 and 7 μM for the pyrimidine analogs 5-fluorouracil and 4-thiouracil, respectively. Size exclusion chromatography revealed the native LdUPRT to be tetrameric and retained partial structure and activity in high concentrations of urea. L. donovani mutants deficient in de novo pyrimidine biosynthesis, which require functional LdUPRT for growth, are hypersensitive to high concentrations of uracil, 5-fluorouracil, and 4-thiouracil in the growth medium. This hypersensitivity can be explained by the observation that LdUPRT is substrate-inhibited by uracil and 4-thiouracil, but 5-fluorouracil toxicity transpires via an alternative mechanism. This substrate inhibition of LdUPRT provides a protective mechanism for the parasite by facilitating purine and pyrimidine nucleotide pool balance and by sparing phosphoribosylpyrophosphate for consumption by the nutritionally indispensable purine salvage process.
AuthorsRadika Soysa, Zachary N Wilson, Johannes Elferich, Isaac Forquer, Ujwal Shinde, Michael K Riscoe, Phillip A Yates, Buddy Ullman
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 288 Issue 41 Pg. 29954-64 (Oct 11 2013) ISSN: 1083-351X [Electronic] United States
PMID23986453 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Cations, Divalent
  • Protozoan Proteins
  • Pyrimidines
  • Recombinant Proteins
  • Uracil
  • 4-thiouracil
  • Thiouracil
  • Phosphoribosyl Pyrophosphate
  • Pentosyltransferases
  • uracil phosphoribosyltransferase
  • pyrimidine
  • Fluorouracil
Topics
  • Cations, Divalent (chemistry, metabolism)
  • Chromatography, Gel
  • Enzyme Stability
  • Feedback, Physiological (drug effects)
  • Fluorouracil (metabolism)
  • Hydrogen-Ion Concentration
  • Kinetics
  • Leishmania donovani (enzymology, genetics, metabolism)
  • Mutation
  • Pentosyltransferases (chemistry, genetics, metabolism)
  • Phosphoribosyl Pyrophosphate (metabolism)
  • Protein Multimerization
  • Protozoan Proteins (chemistry, genetics, metabolism)
  • Pyrimidines (biosynthesis, pharmacology)
  • Recombinant Proteins (chemistry, metabolism)
  • Spectrophotometry
  • Substrate Specificity
  • Temperature
  • Thiouracil (analogs & derivatives, metabolism)
  • Uracil (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: